Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans

Journal of Neuroendocrinology

Volumn 23, Issue 6, 2011, Pages 501-507

  Elias, E ^a   Benrick, A ^a   Behre, C J ^b   Ekman, R ^a   Zetterberg, H ^a   Stenlof K ^a   Wallenius, V ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; HPA axis; Leptin; Lipocalins type prostaglandin D2 synthase; Neuropeptide Y; Obesity; Orexigenic; Visceral

Indexed keywords

ALBUMIN; APPETITE STIMULANT; BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; GALANIN; INSULIN; LEPTIN; LIPOCALIN TYPE PROSTAGLANDIN D2 SYNTHASE; NEUROPEPTIDE Y; PROSTAGLANDIN D2 DERIVATIVE; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; APPETITE; ARTICLE; BLOOD SAMPLING; BODY FAT DISTRIBUTION; BODY MASS; CALORIC RESTRICTION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL EVALUATION; CONCENTRATION (PARAMETERS); CORRELATION ANALYSIS; DIET THERAPY; FOOD INTAKE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; OBESITY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REGULATORY MECHANISM; WEIGHT REDUCTION;

ADIPOSITY; ADULT; AGED; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTRA-ABDOMINAL FAT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRAMOLECULAR OXIDOREDUCTASES; LEPTIN; LIPOCALINS; MALE; MIDDLE AGED; NEUROPEPTIDES; OBESITY; PITUITARY-ADRENAL SYSTEM; PLACEBOS;

EID: 79955969996     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02128.x     Document Type: Article

References (31)

1. Schlehuber S, Skerra A. Lipocalins in drug discovery: from natural ligand-binding proteins to "anticalins". Drug Discov Today 2005; 10: 23-33.
2. Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 1993; 90: 9070-9074.
3. Mohri I, Eguchi N, Suzuki K, Urade Y, Taniike M. Hematopoietic prostaglandin D synthase is expressed in microglia in the developing postnatal mouse brain. Glia 2003; 42: 263-274.
4. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 1994; 91: 11192-11196.
5. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, Nagata K. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193: 255-261.
6. Hayaishi O, Urade Y. Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. Neuroscientist 2002; 8: 12-15.
7. Eguchi N, Minami T, Shirafuji N, Kanaoka Y, Tanaka T, Nagata A, Yoshida N, Urade Y, Ito S, Hayaishi O. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 1999; 96: 726-730.
8. Ueno R, Narumiya S, Ogorochi T, Nakayama T, Ishikawa Y, Hayaishi O. Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1982; 79: 6093-6097.
9. Ohinata K, Takagi K, Biyajima K, Fujiwara Y, Fukumoto S, Eguchi N, Urade Y, Asakawa A, Fujimiya M, Inui A, Yoshikawa M. Central prostaglandin D(2) stimulates food intake via the neuropeptide Y system in mice. FEBS Lett 2008; 582: 679-684.
10. Fujitani Y, Aritake K, Kanaoka Y, Goto T, Takahashi N, Fujimori K, Kawada T. Pronounced adipogenesis and increased insulin sensitivity caused by overproduction of prostaglandin D2 in vivo. FEBS J 2010; 277: 1410-1419.
11. Tanaka R, Miwa Y, Mou K, Tomikawa M, Eguchi N, Urade Y, Takahashi-Yanaga F, Morimoto S, Wake N, Sasaguri T. Knockout of the l-pgds gene aggravates obesity and atherosclerosis in mice. Biochem Biophys Res Commun 2009; 378: 851-856.
12. Zelissen PM, Stenlof K, Lean ME, Fogteloo J, Keulen ET, Wilding J, Finer N, Rossner S, Lawrence E, Fletcher C, McCamish M. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial. Diabetes Obes Metab 2005; 7: 755-761.
13. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO. Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 2003; 88: 4379-4383.
14. Chowdhury B, Sjostrom L, Alpsten M, Kostanty J, Kvist H, Lofgren R. A multicompartment body composition technique based on computerized tomography. Int J Obes Relat Metab Disord 1994; 18: 219-234.
15. Hunter WM, Greenwood FC. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495-496.
16. Ekman R, Servenius B, Castro MG, Lowry PJ, Cederlund AS, Bergman O, Sjogren HO. Biosynthesis of corticotropin-releasing hormone in human T-lymphocytes. J Neuroimmunol 1993; 44: 7-13.
17. Heilig M, Ekman R. Chronic parenteral antidepressant treatment in rats: unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochem Int 1995; 26: 351-355.
18. Bramnert M, Ekman R, Larsson I, Thorell JI. Characterization and application of a radioimmunoassay for beta-endorphin using an antiserum with negligible cross-reactivity against beta-lipotropin. Regul Pept 1982; 5: 65-75.
19. Winther Bach F, Ekman R, Jensen FM. Beta-endorphin-immunoreactive components in human cerebrospinal fluid. Regul Pept 1986; 4: 189-198.
20. Ekblad E, Arnbjornsson E, Ekman R, Hakanson R, Sundler F. Neuropeptides in the human appendix. Distribution and motor effects. Dig Dis Sci 1989; 34: 1217-1230.
21. Chiba T, Komatsu T, Nakayama M, Adachi T, Tamashiro Y, Hayashi H, Yamaza H, Higami Y, Shimokawa I. Similar metabolic responses to calorie restriction in lean and obese Zucker rats. Mol Cell Endocrinol 2009; 309: 17-25.
22. Kinzig KP, Hargrave SL, Tao EE. Central and peripheral effects of chronic food restriction and weight restoration in the rat. Am J Physiol Endocrinol Metab 2009; 296: E282-E290.
23. Gao W, Schmidtko A, Wobst I, Lu R, Angioni C, Geisslinger G. Prostaglandin D2 produced by hematopoietic prostaglandin D synthase contributes to LPS-induced fever. J Physiol Pharmacol 2009; 60: 145-150.
24. Poritsanos NJ, Mizuno TM, Lautatzis ME, Vrontakis M. Chronic increase of circulating galanin levels induces obesity and marked alterations in lipid metabolism similar to metabolic syndrome. Int J Obes (Lond) 2009; 33: 1381-1389.
25. Mitsukawa K, Lu X, Bartfai T. Galanin, galanin receptors and drug targets. Cell Mol Life Sci 2008; 65: 1796-1805.
26. Adams AC, Clapham JC, Wynick D, Speakman JR. Feeding behaviour in galanin knockout mice supports a role of galanin in fat intake and preference. J Neuroendocrinol 2008; 20: 199-206.
27. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009; 94: 2692-2701.
28. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamic-pituitary-adrenal axis activity in obesity and the metabolic syndrome. Ann NY Acad Sci 2006; 1083: 111-128.
29. Garcia-Fernandez LF, Iniguez MA, Eguchi N, Fresno M, Urade Y, Munoz A. Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J Neurochem 2000; 75: 460-470.
30. Elander L, Engstrom L, Ruud J, Mackerlova L, Jakobsson PJ, Engblom D, Nilsberth C, Blomqvist A. Inducible prostaglandin E2 synthesis interacts in a temporally supplementary sequence with constitutive prostaglandin-synthesizing enzymes in creating the hypothalamic-pituitary-adrenal axis response to immune challenge. J Neurosci 2009; 29: 1404-1413.
31. Ohinata K, Yoshikawa M. Central prostaglandins in food intake regulation. Nutrition 2008; 24: 798-801.